(Q36536020)

14 August 2017

The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population (English)

1 reference

14 August 2017

1 reference

1 reference

Kim Brosen

3

0 references

author name string

Jónrit Halling

series ordinal

1

1 reference

14 August 2017

Pál Weihe

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

31 August 2007

1 reference

British Journal of Clinical Pharmacology

14 August 2017

1 reference

14 August 2017

65

1 reference

14 August 2017

1

1 reference

14 August 2017

134-138

1 reference

The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Some aspects of genetic polymorphism in the biotransformation of antidepressants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Sparteine metabolism in Canadian Caucasians

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Sparteine oxidation polymorphism in Denmark.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Affinity of nortriptyline and its E-10-hydroxy metabolite for muscarinic receptors.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Outpatient utilization of antidepressants: a prescription database analysis.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

Enantioselective hydroxylation of nortriptyline in human liver microsomes, intestinal homogenate, and patients treated with nortriptyline

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291274

E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation

21 September 2018

1 reference

12 December 2020

Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man

1 reference

12 December 2020

Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings

1 reference

12 December 2020

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

1 reference

12 December 2020

Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes

1 reference

12 December 2020

High-performance liquid chromatography of clomipramine and metabolites in human plasma and urine

1 reference

12 December 2020

High incidence of cystic fibrosis on the Faroe Islands: a molecular and genealogical study

1 reference

12 December 2020

Antidepressant and anxiolytic profiles of E-10-hydroxynortriptyline on electrocorticograms of rats

1 reference

12 December 2020

Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands

1 reference

12 December 2020

Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline

1 reference

12 December 2020

10.1111/J.1365-2125.2007.02969.X

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

17764479

1 reference